Akari Therapeutics (NASDAQ:AKTX) Coverage Initiated by Analysts at StockNews.com
StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research report sent to investors on Sunday. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Down 2.1 % AKTX stock opened at $1.43 on Friday. The company has a fifty day moving average price of […]
StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research report sent to investors on Sunday. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Down 2.1 % AKTX stock opened at $1.43 on Friday. The company has a fifty day moving average price of […]
